US E-cigarette Summit 2018: Washington DC

Hello all!  It’s Dawn, here again, your loyal A Clean Cigarette brand e-cigarette blogger and I hope everyone is having a great day.

It’s that time of year again. That time where we here at A Clean Cigarette travel to our Nations great Capitol and have an opportunity to hear what the scientific and regulatory communities are thinking when it comes to E-cigarettes and Vapor products.

Today we are going to get right to the third and final part of our coverage of the Electronic Cigarette Summit that took place in Washington DC. This will be the last part of our E-cigarette Summit coverage but it is certainly not the least of them.

Keep in mind that unlike some of our opinion post this post is designed to report on the events that happened at this summit. Not to report our opinions or to make any claims. These experts and scientist are doing research to find the truth but until the FDA has decided on how things can be said we will not be making any claims we will only be reporting on the findings. A Clean Cigarette is not an FDA approved smoking cessation product and has not been evaluated by the FDA as such. E-cigarettes including A Clean Cigarette brand e-cigarettes contain nicotine. Nicotine IS addictive regardless of delivery method. If you are a never smoker, never start.

Let’s get to the good stuff!

The next speaker we are going to talk about and our first speaker today is Dr. Michael Cummings. Dr. Cummings is a Professor in the Department of Psychiatry & Behavioral Sciences at the Medical University of South Carolina where he co-leads the tobacco control research program. Dr. Cummings has participated in some of the only studies done that have look into whether regulations affect the success rate of electronic cigarettes and at what point do regulations do more harm than good.

Here are the findings for the first of those studies: “This is the first study to examine the impact of  regulatory environment for ECs on their real-world effectiveness for smoking cessation. This study shows that in a less restrictive EC regulatory environment, use of ECs during a quit attempt facilitates, but in a more restrictive environment, it inhibits, short-term sustained abstinence. The findings underscore the need for careful consideration on how best to regulate this emerging product so that EC benefits for smoking cessation are maximized and its risks to public health are minimized.”

Speaking topic: Smoking Harm Reduction: If Not Now, When?

“Dr. Cummings will discuss the urgent need to implementing new approaches to help cigarette smokers transition away from cigarettes.  With ½ million deaths from smoking predicted this year in the US and over 6 million worldwide the time to act is now.  Innovations in safer alternative nicotine products offer an opportunity to disrupt the cigarette marketplace in ways that can have a dramatic impact on preventing needless deaths from cigarette addiction.  Public health and the vaping community need to work together to push the cigarette industry into the history books.”

As with many of our speakers this gentleman may look familiar to you. Dr. Niel Benowitz made a repeat appearance again this year and spoke on nearly the same thing as he did last year. Last year when he spoke I made the comment that due to his extream intelligence it was hard for me to follow a lot of what he said. This year thankfully I did not feel quite as lost. Many of the studies Dr. Benowitz spoke about are the same studies that we have been talking about here on the blog. It was very exciting to hear a scientist as highly regarded as Dr. Benowitz brake down that information but there was ALOT of it. Basically though according to Dr. Benowitze, while e-cigarettes are NOT harmless they are less harmless than a burning tobacco cigarette, however, special attention should be made to make people aware that one of e-cigarettes harms is that they ARE addictive because they deliver nicotine.

Speaking topic: Relative Risks of Electronic Cigarettes

“Benowitz will discuss safety concerns with use of E-cigarettes, including toxicant exposure, nicotine addiction and cardiopulmonary disease. He will explore the relative risk values between different types of e-cigarettes, for example, higher powered devices versus products with higher nicotine content and comment on how safety should be considered within a broader context of smokers needs and regulation.”

Clive Bates is a name we have talked about many times here on the A Clean Cigarette Blog. He is a staunch supporter of e-cigarettes and vapor products and he is very vocal in his support of flavors for e-cigarettes. As an activist, Clive has his own website and he has attached a video of his speech at the 2018 E-Cigarette Summit. If you are interested in hearing what he has to say click HERE.

Speaking topic: Vaping and Kids – How to Make Sense of the Controversies in 10 Questions

Controversies surrounding e-cigarettes are not new, but recent reports on the growing popularity of JUUL and “kiddie appealing” flavors have created a moral panic.  This session will ask if we can establish a framework for investigating the effect of products such as JUUL and flavors on vaping and smoking behaviors? What do we need to do to show that flavors change behavior, and how do we establish whether these effects are harmful or beneficial?  Through a sequence of 10 questions, we will interrogate these subtle issues.


Deborah Arnott is a Chief Executive of ASH (Action on Smoking and Health)  which is a UK based organization we have talked about many times during this 3 part Summit Overview. She was also at last years event. She is adamite that the risk to children is just too high to allow for anything less than a pharmaceutical type licensing situation.

Ms. Arnott is a recognized expert in the tobacco harm reduction field and she has worked closely with both the UK and the USA in their efforts to regulate the ENDS industry.

Speaking topic: Regulatory Framework for E-Cigarettes in the EU

From 2016 onwards the Tobacco Products Directive introduced regulations for e-cigarettes which provide a consistent regulatory framework across the whole of the EU, with 28 member states and a population of over 500 million. This session will explain how the regulatory framework establishes a notification system for consumer products which has allowed the independent e-cigarette sector to continue to flourish, with the option left open to apply for more stringent medicines licensing. It will go on to explain how the regulatory system in the UK, while conforming to the EU rules, is embedded within a strategy for driving down smoking prevalence which is the most advanced in Europe and what the implications of that have been. It will also point out the differences between the EU and the US systems, and what the implications of these differences are.

Dr. David Abrams PhD comes to us out of New York University although he had degrees from all over. He had a hard time understanding how the same people that worked so hard for so many years to beat big tobacco are now working against an industry that appears to be making real headway against it. He pointed at the fact that for the first time in history Big Tobacco companies are reporting profit loss and market share reduction. He went on to ask Why would we demonize nicotine when it was never nicotine that was the bad guy when it comes to burning tobacco-related illnesses?

One particularly powerful quote from his lecture: “Misleading the public to protect the kids is harmful and unethical”

Speaking topic: Finding the Sweet Spot. Science is Re-Framing Nicotine Use to Save Lives More Rapidly

“Absent massive changes in behavior, 7.2 million people worldwide will continue to die each year. An array of non-combustible nicotine products (NNPs) has emerged. For the first time in 120 years, evidence is mounting that NNPs can be the “sweet spot” to disrupt and displace the global dominance of cigarettes that persists despite tobacco control’s best efforts. Smoking control – not tobacco or nicotine control – embraces use of appealing and economically viable NNPs as part of the solution to the cause of health harms—smoke. NNPs can be smoking control’s valued ally to eliminate the smoking epidemic. We must address the false equivalence of promoting weak headline grabbing studies that exaggerate the harms of NNPs, undermining harm minimization efforts and perpetuating smoking behaviour. A synthesis of the stronger scientific evidence provides our guidance. Influential leaders must align and speak with one voice to reassure smokers and those who care about smokers that nicotine is not the major source of harm and that a switch to NNPs will improve their health.”

Wow, that was a lot of information. I know that there is a lot more then what I have reported what happened at the Summit. I could go on for another 5 parts and still not have everything reported on. Don’t worry I won’t lol but if you have particular questions about any of these speakers or anything else please feel free to drop me a line in the comments below or reach out on our FB page. I will do my best to get you the answers you deserve.

If you or a loved one would like more information on A Clean Cigarette brand electronic cigarette please visit

Thank you so much for staying informed about this industry. Share this around to help us spread awareness about the real science regarding e-cigarettes and vapor products. Have a great day!!






Leave a comment

Comments will be approved before showing up.